Luebeck, Germany

Frank Noack

This inventor holds 1 USPTO granted patent. Top assignee: Wilex Ag. Active years: 2007.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Frank Noack. Retrieved from https://idiyas.com/inventor/frank-noack-6b62kvde

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 8(Granted Patents)


Company Filing History:


Years Active: 2007

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Frank Noack: Innovator in Diagnostic and Therapeutic Applications

Introduction

Frank Noack is a notable inventor based in Lübeck, Germany. He has made significant contributions to the field of diagnostics and therapeutics, particularly through his innovative work involving antibodies.

Latest Patents

Frank Noack holds 1 patent for his invention titled "Diagnostic and therapeutic use of antibodies against the urokinase receptor." This invention focuses on a method and a reagent kit designed for detecting cells in a biological sample using a double-fluorescence technique. The patent emphasizes the diagnostic and therapeutic application of amino acid sequence-specific antibodies against the urokinase receptor, which exhibit a high affinity for tumor cell-expressed receptors.

Career Highlights

Frank Noack is associated with Wilex AG, a company that specializes in developing innovative solutions in the field of cancer diagnostics and therapeutics. His work has been instrumental in advancing the understanding and treatment of various cancers.

Collaborations

Throughout his career, Frank Noack has collaborated with esteemed colleagues such as Manfred Schmitt and Henner Graeff. These partnerships have contributed to the development of groundbreaking technologies in the medical field.

Conclusion

Frank Noack's contributions to the field of diagnostics and therapeutics highlight his role as an innovator. His patent on the use of antibodies against the urokinase receptor showcases his commitment to advancing medical science.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…